Principia Biopharma to Present at the 2019 Bank of America Merrill Lynch Health Care Conference

NEXT STORY
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2019 Financial Results
PREV STORY
Melinta Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Arog Pharmaceuticals Receives Orphan Drug Designation in the European Union for Crenolanib for the Treatment of Acute Myeloid Leukemia and Soft Tissue Sarcoma

DALLAS, Nov. 21, 2016 (GLOBE NEWSWIRE) -- Arog Pharmaceuticals, Inc., a privately held, clinical-stage ...

author_avatar
NASDAQ Market News

Junshi Biosciences Announces Acceptance by NMPA of Supplemental New Drug Application for Toripalimab Plus Chemotherapy as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma

author_avatar
NASDAQ Market News

Axogen, Inc. Announces Completion of Planned Interim Analysis and One-Time Enrollment Expansion for RECON® Study

author_avatar
NASDAQ Market News